Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	glycogen phosphorylase activity	PYGB PYGL PYGM	1.54e-07	3	108	3	GO:0008184
GeneOntologyMolecularFunction	xenobiotic transmembrane transporter activity	ABCC1 ABCA3 ABCC11 ABCA8 SLC18A1	1.04e-06	34	108	5	GO:0042910
GeneOntologyMolecularFunction	ABC-type xenobiotic transporter activity	ABCC1 ABCA3 ABCC11 ABCA8	1.06e-06	15	108	4	GO:0008559
GeneOntologyMolecularFunction	1,4-alpha-oligoglucan phosphorylase activity	PYGB PYGL PYGM	1.53e-06	5	108	3	GO:0004645
GeneOntologyMolecularFunction	ATP hydrolysis activity	ABCC1 ABCA3 ABCC11 CHD9 RUVBL2 ABCA8 DDX6 HSPA13 ATP2A2 DYNC1H1 ALPL KIFC1	4.77e-06	441	108	12	GO:0016887
GeneOntologyMolecularFunction	ATP-dependent activity	ABCC1 ABCA3 ABCC11 CHD9 RUVBL2 ABCA8 DDX6 HSPA13 MSH6 DNAH17 ATP2A2 DYNC1H1 ALPL KIFC1	5.69e-06	614	108	14	GO:0140657
GeneOntologyMolecularFunction	ABC-type transporter activity	ABCC1 ABCA3 ABCC11 ABCA8	1.42e-04	49	108	4	GO:0140359
GeneOntologyMolecularFunction	pyridoxal phosphate binding	AGXT2 PYGB PYGL PYGM	2.39e-04	56	108	4	GO:0030170
GeneOntologyMolecularFunction	vitamin B6 binding	AGXT2 PYGB PYGL PYGM	2.56e-04	57	108	4	GO:0070279
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	ABCC1 ABCA3 ABCC11 CHD9 RUVBL2 ABCA8 DDX6 HSPA13 ATP2A2 DYNC1H1 SEPTIN12 ALPL KIFC1	2.82e-04	775	108	13	GO:0017111
GeneOntologyMolecularFunction	ATPase-coupled transmembrane transporter activity	ABCC1 ABCA3 ABCC11 ABCA8 ATP2A2	3.15e-04	109	108	5	GO:0042626
GeneOntologyMolecularFunction	pyrophosphatase activity	ABCC1 ABCA3 ABCC11 CHD9 RUVBL2 ABCA8 DDX6 HSPA13 ATP2A2 DYNC1H1 SEPTIN12 ALPL KIFC1	5.99e-04	839	108	13	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	ABCC1 ABCA3 ABCC11 CHD9 RUVBL2 ABCA8 DDX6 HSPA13 ATP2A2 DYNC1H1 SEPTIN12 ALPL KIFC1	6.06e-04	840	108	13	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	ABCC1 ABCA3 ABCC11 CHD9 RUVBL2 ABCA8 DDX6 HSPA13 ATP2A2 DYNC1H1 SEPTIN12 ALPL KIFC1	6.06e-04	840	108	13	GO:0016818
GeneOntologyMolecularFunction	ABC-type glutathione S-conjugate transporter activity	ABCC1 ABCC11	7.94e-04	8	108	2	GO:0015431
GeneOntologyMolecularFunction	ATPase-coupled lipid transmembrane transporter activity	ABCC1 ABCC11	1.02e-03	9	108	2	GO:0034040
GeneOntologyMolecularFunction	ATPase-coupled inorganic anion transmembrane transporter activity	ABCC1 ABCC11	1.27e-03	10	108	2	GO:0043225
Domain	PHOSPHORYLASE	PYGB PYGL PYGM	1.68e-07	3	104	3	PS00102
Domain	Glycg_phsphrylas	PYGB PYGL PYGM	1.68e-07	3	104	3	IPR011833
Domain	Glyco_trans_35	PYGB PYGL PYGM	1.68e-07	3	104	3	IPR000811
Domain	Phosphorylase	PYGB PYGL PYGM	1.68e-07	3	104	3	PF00343
Domain	Ifi-6-16	IFI27L2 IFI27 IFI27L1	6.68e-07	4	104	3	PF06140
Domain	IFI6/IFI27	IFI27L2 IFI27 IFI27L1	6.68e-07	4	104	3	IPR009311
Domain	Calponin_repeat	TAGLN3 CNN1 CNN3	3.31e-06	6	104	3	IPR000557
Domain	Calponin	TAGLN3 CNN1 CNN3	3.31e-06	6	104	3	PF00402
Domain	CALPONIN_1	TAGLN3 CNN1 CNN3	3.31e-06	6	104	3	PS01052
Domain	CALPONIN_2	TAGLN3 CNN1 CNN3	3.31e-06	6	104	3	PS51122
Domain	SM22_calponin	TAGLN3 CNN1 CNN3	2.68e-05	11	104	3	IPR003096
Domain	ABC_tran	ABCC1 ABCA3 ABCC11 ABCA8	1.46e-04	48	104	4	PF00005
Domain	ABC_TRANSPORTER_2	ABCC1 ABCA3 ABCC11 ABCA8	1.46e-04	48	104	4	PS50893
Domain	AAA	ABCC1 ABCA3 ABCC11 RUVBL2 ABCA8 DYNC1H1	1.54e-04	144	104	6	SM00382
Domain	AAA+_ATPase	ABCC1 ABCA3 ABCC11 RUVBL2 ABCA8 DYNC1H1	1.54e-04	144	104	6	IPR003593
Domain	ABC_TRANSPORTER_1	ABCC1 ABCA3 ABCC11 ABCA8	1.59e-04	49	104	4	PS00211
Domain	ABC_transporter-like	ABCC1 ABCA3 ABCC11 ABCA8	1.72e-04	50	104	4	IPR003439
Domain	Calponin/LIMCH1	CNN1 CNN3	1.83e-04	4	104	2	IPR001997
Domain	Cadherin_C	DSC3 CDH24 CDH10	3.53e-04	25	104	3	PF01049
Domain	Cadherin_cytoplasmic-dom	DSC3 CDH24 CDH10	3.53e-04	25	104	3	IPR000233
Domain	Catenin_binding_dom	DSC3 CDH24 CDH10	5.52e-04	29	104	3	IPR027397
Domain	-	DSC3 CDH24 CDH10	5.52e-04	29	104	3	4.10.900.10
Domain	DUF3699	GARIN4 GARIN3	1.08e-03	9	104	2	IPR022168
Domain	DUF3699	GARIN4 GARIN3	1.08e-03	9	104	2	PF12480
Domain	Pep_M12B_propep	ADAM11 ADAM12 ADAMTS18	1.33e-03	39	104	3	PF01562
Domain	Peptidase_M12B_N	ADAM11 ADAM12 ADAMTS18	1.33e-03	39	104	3	IPR002870
Domain	DISINTEGRIN_1	ADAM11 ADAM12 ADAMTS18	1.43e-03	40	104	3	PS00427
Domain	Reprolysin	ADAM11 ADAM12 ADAMTS18	1.43e-03	40	104	3	PF01421
Domain	ADAM_MEPRO	ADAM11 ADAM12 ADAMTS18	1.43e-03	40	104	3	PS50215
Domain	DISINTEGRIN_2	ADAM11 ADAM12 ADAMTS18	1.43e-03	40	104	3	PS50214
Domain	Peptidase_M12B	ADAM11 ADAM12 ADAMTS18	1.43e-03	40	104	3	IPR001590
Domain	Disintegrin_dom	ADAM11 ADAM12 ADAMTS18	1.53e-03	41	104	3	IPR001762
Domain	ABC_transporter_CS	ABCC1 ABCA3 ABCC11	1.64e-03	42	104	3	IPR017871
Domain	ABC_A	ABCA3 ABCA8	1.95e-03	12	104	2	IPR026082
Domain	P-loop_NTPase	ABCC1 NLRP12 ABCA3 ABCC11 CHD9 RUVBL2 ABCA8 DDX6 MSH6 DYNC1H1 SEPTIN12 KIFC1	2.65e-03	848	104	12	IPR027417
Domain	-	ABCC1 NLRP12 ABCA3 ABCC11 CHD9 RUVBL2 ABCA8 DDX6 MSH6 DYNC1H1 SEPTIN12	2.93e-03	746	104	11	3.40.50.300
Domain	Cadherin_CS	DSC3 PCDHGA1 CDH24 CDH10	3.23e-03	109	104	4	IPR020894
Domain	Disintegrin_CS	ADAM11 ADAM12	3.50e-03	16	104	2	IPR018358
Domain	CADHERIN_1	DSC3 PCDHGA1 CDH24 CDH10	3.67e-03	113	104	4	PS00232
Domain	Cadherin	DSC3 PCDHGA1 CDH24 CDH10	3.67e-03	113	104	4	PF00028
Domain	CADHERIN_2	DSC3 PCDHGA1 CDH24 CDH10	3.79e-03	114	104	4	PS50268
Domain	-	DSC3 PCDHGA1 CDH24 CDH10	3.79e-03	114	104	4	2.60.40.60
Domain	CA	DSC3 PCDHGA1 CDH24 CDH10	3.91e-03	115	104	4	SM00112
Domain	Cadherin-like	DSC3 PCDHGA1 CDH24 CDH10	4.03e-03	116	104	4	IPR015919
Domain	Cadherin	DSC3 PCDHGA1 CDH24 CDH10	4.28e-03	118	104	4	IPR002126
Domain	ADAM_CR	ADAM11 ADAM12	4.43e-03	18	104	2	PF08516
Domain	-	ADAM11 ADAM12	5.47e-03	20	104	2	4.10.70.10
Domain	PWWP	MSH6 GLYR1	5.47e-03	20	104	2	SM00293
Pathway	KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION	PYGB PYGL PYGM	1.44e-05	9	80	3	M47621
Pathway	REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS	PYGB PYGL PYGM	6.12e-05	14	80	3	M19193
Pathway	REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP	CYP51A1 CHD9 CREBBP LSS	9.14e-05	42	80	4	M27172
Pathway	KEGG_ABC_TRANSPORTERS	ABCC1 ABCA3 ABCC11 ABCA8	1.10e-04	44	80	4	M11911
Pathway	REACTOME_TRANSPORT_OF_SMALL_MOLECULES	ABCC1 ABCA3 SLC2A14 ABCC11 ADCY3 ABCA8 ADD1 SLC44A5 AP2B1 SLC18A1 ATP2A2 SLC4A5 CA4	2.37e-04	736	80	13	M27287
Pathway	REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF	CYP51A1 CHD9 CREBBP LSS	2.63e-04	55	80	4	M27001
Pathway	REACTOME_METABOLISM_OF_LIPIDS	ABCC1 MED8 CYP51A1 OXCT2 PTGR2 CHD9 CREBBP GK LIPE SLC44A5 PI4KA LSS ACOXL	3.12e-04	757	80	13	M27451
Pathway	REACTOME_GLYCOGEN_METABOLISM	PYGB PYGL PYGM	3.70e-04	25	80	3	M27857
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	POLR1A DSC3 DLGAP5 RUVBL2 CREBBP DDX6 TMEM33 MSH6 ALKBH1 AP2B1 PI4KA GLYR1 CPSF1 PYGB PYGL NOP2 ATP2A2 YTHDF2 DYNC1H1	5.55e-08	1353	111	19	29467282
Pubmed	ISG12 is a critical modulator of innate immune responses in murine models of sepsis.	IFI27L2 IFI27 IFI27L1	1.26e-07	4	111	3	23747037
Pubmed	Identification of a novel gene family that includes the interferon-inducible human genes 6-16 and ISG12.	IFI27L2 IFI27 IFI27L1	1.26e-07	4	111	3	14728724
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	POLR1A CYP51A1 DDX6 TMEM33 MSH6 AP2B1 GLYR1 CPSF1 PYGB NNT YTHDF2 DYNC1H1	1.51e-07	534	111	12	35032548
Pubmed	The interferon stimulated gene 12 inactivates vasculoprotective functions of NR4A nuclear receptors.	IFI27L2 IFI27 IFI27L1	3.15e-07	5	111	3	22427340
Pubmed	Apoptotic properties of the type 1 interferon induced family of human mitochondrial membrane ISG12 proteins.	IFI27L2 IFI27 IFI27L1	3.15e-07	5	111	3	27673746
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	DAB2IP KCTD9 DLGAP5 ADGRB3 NBEA ARMCX4 PPM1H ADD1 AP2B1 ANAPC1 PI4KA TAGLN3 NOP2 CDH10 DYNC1H1	4.43e-07	963	111	15	28671696
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	CNOT11 POLR1A RUVBL2 ADD1 DDX6 TMEM33 CELF2 ANAPC1 NOP2 ATP2A2 NNT YTHDF2 CNN3	5.73e-07	724	111	13	36232890
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	RASGRP4 EBF1 ADCY3 TMEM33 LIPE ASCL1 PI4KA PYGB DYNC1H1	9.88e-07	322	111	9	26514267
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	POLR1A MSH6 AP2B1 ANAPC1 GLYR1 CPSF1 PYGB PYGL NOP2 ATP2A2 NNT DYNC1H1	1.26e-06	653	111	12	22586326
Pubmed	Analysis of a lung defect in autophagy-deficient mouse strains.	ABCA3 PYGB PYGL PYGM	1.39e-06	26	111	4	24275123
Pubmed	Rearrangement of the Protein Phosphatase 1 Interactome During Heart Failure Progression.	KCTD9 RUVBL2 CREBBP PYGB PYGM ATP2A2 YTHDF2	1.52e-06	174	111	7	29669786
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	CNOT11 CYP51A1 ADD1 MSH6 AP2B1 ANAPC1 PYGB LSS NNT DYNC1H1 CNN3	1.90e-06	560	111	11	35241646
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	MED8 CHD9 RREB1 RUVBL2 CREBBP DDX6 MSH6 ARID1B CELF2 AP2B1 PYGL NOP2 ATP2A2 DYNC1H1 KIFC1	2.38e-06	1103	111	15	34189442
Pubmed	Mechanisms and Consequences of Dopamine Depletion-Induced Attenuation of the Spinophilin/Neurofilament Medium Interaction.	RELCH PCLO ADD1 AP2B1 PYGM ATP2A2	4.17e-06	131	111	6	28634551
Pubmed	A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export.	POLR1A CYP51A1 RUVBL2 MSH6 SLC49A4 PYGL ATP2A2 YTHDF2 DYNC1H1	4.92e-06	392	111	9	33144569
Pubmed	Neurog2 simultaneously activates and represses alternative gene expression programs in the developing neocortex.	SOX6 EBF1 ASCL1	8.84e-06	13	111	3	22735158
Pubmed	Age-dependent resistance to lethal alphavirus encephalitis in mice: analysis of gene expression in the central nervous system and identification of a novel interferon-inducible protective gene, mouse ISG12.	IFI27L2 IFI27L1	1.01e-05	2	111	2	12388728
Pubmed	ALKBH1 contributes to renal cell carcinoma progression by reducing N6-methyladenine of GPR137.	GPR137 ALKBH1	1.01e-05	2	111	2	36920340
Pubmed	Molecular cloning and gene mapping of human basic and acidic calponins.	CNN1 CNN3	1.01e-05	2	111	2	8526917
Pubmed	The Interferon-Stimulated Gene Ifi27l2a Restricts West Nile Virus Infection and Pathogenesis in a Cell-Type- and Region-Specific Manner.	IFI27L2 IFI27L1	1.01e-05	2	111	2	26699642
Pubmed	The interferon-induced gene Ifi27l2a is active in lung macrophages and lymphocytes after influenza A infection but deletion of Ifi27l2a in mice does not increase susceptibility to infection.	IFI27L2 IFI27L1	1.01e-05	2	111	2	25184786
Pubmed	Isoform-selective regulation of glycogen phosphorylase by energy deprivation and phosphorylation in astrocytes.	PYGB PYGM	1.01e-05	2	111	2	25130497
Pubmed	Identification of ISG12b as a putative interferon-inducible adipocytokine which is highly expressed in white adipose tissue.	IFI27L2 IFI27L1	1.01e-05	2	111	2	17704618
Pubmed	Interferon-stimulated gene ISG12b1 inhibits adipogenic differentiation and mitochondrial biogenesis in 3T3-L1 cells.	IFI27L2 IFI27L1	1.01e-05	2	111	2	18948406
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	MED8 RUVBL2 CREBBP ADD1 TMEM33 MSH6 ARID1B ANAPC1 DYNC1H1 CNN3	1.10e-05	549	111	10	38280479
Pubmed	Localization of the muscle, liver, and brain glycogen phosphorylase genes on linkage maps of mouse chromosomes 19, 12, and 2, respectively.	PYGB PYGL PYGM	1.40e-05	15	111	3	2575583
Pubmed	140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry.	RELCH ADD1 AP2B1 PI4KA PYGB DYNC1H1	1.46e-05	163	111	6	16512683
Pubmed	HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways.	CYP51A1 RUVBL2 DDX6 TMEM33 ANAPC1 PI4KA PYGL ATP2A2 YTHDF2 DYNC1H1	1.54e-05	571	111	10	37167062
Pubmed	Inhibition of p300/CBP by early B-cell factor.	EBF1 CREBBP	3.02e-05	3	111	2	12748286
Pubmed	Functional analysis of rat acidic calponin.	CNN1 CNN3	3.02e-05	3	111	2	12033495
Pubmed	Frameshift mutations of cadherin genes DCHS2, CDH10 and CDH24 genes in gastric and colorectal cancers with high microsatellite instability.	CDH24 CDH10	3.02e-05	3	111	2	24898286
Pubmed	Cloning and initial characterization of mouse meltrin beta and analysis of the expression of four metalloprotease-disintegrins in bone cells.	ADAM11 ADAM12	3.02e-05	3	111	2	9461614
Pubmed	Tyrosine phosphorylation of calponins. Inhibition of the interaction with F-actin.	CNN1 CNN3	3.02e-05	3	111	2	15206927
Pubmed	The DDX6/KIFC1 signaling axis, as regulated by YY1, contributes to the malignant behavior of pancreatic cancer.	DDX6 KIFC1	3.02e-05	3	111	2	38551642
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	PCLO NBEA RUVBL2 MSH6 CELF2 TAGLN3 PYGL LSS CNN3	3.27e-05	498	111	9	36634849
Pubmed	Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins.	ABCC1 CARMIL3 PCLO CREBBP TMEM33 AP2B1 GLYR1 SLC49A4 ATP2A2	3.32e-05	499	111	9	22810586
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	DAB2IP PCLO NBEA AP2B1 PI4KA CDH10 DYNC1H1	3.46e-05	281	111	7	28706196
Pubmed	Sequence organization and matrix attachment regions of the human serine protease inhibitor gene cluster at 14q32.1.	IFI27L2 IFI27 IFI27L1	4.04e-05	21	111	3	15014966
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	DSC3 ITGA4 RUVBL2 ADD1 DDX6 TMEM33 MSH6 AP2B1 GLYR1 CPSF1 NOP2 YTHDF2 DYNC1H1 KIFC1	4.84e-05	1257	111	14	36526897
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	POLR1A CYP51A1 RUVBL2 DDX6 TMEM33 MSH6 ANAPC1 CPSF1 PYGB PYGL NOP2 ATP2A2 YTHDF2 DYNC1H1	4.84e-05	1257	111	14	37317656
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	POLR1A PCLO RUVBL2 DDX6 TMEM33 MSH6 ANAPC1 PI4KA GLYR1 CPSF1 NOP2 ATP2A2 NNT DYNC1H1 KIFC1	4.85e-05	1425	111	15	30948266
Pubmed	Human transcription factor protein interaction networks.	SOX6 CNOT11 MED8 RREB1 RUVBL2 CREBBP ZBTB7A ARID1B GLYR1 CPSF1 NOP2 ATP2A2 YTHDF2 DYNC1H1 KIFC1	5.01e-05	1429	111	15	35140242
Pubmed	Identification of 18 mouse ABC genes and characterization of the ABC superfamily in Mus musculus.	ABCC1 ABCA3 ABCA8	5.35e-05	23	111	3	10708515
Pubmed	Association of lifestyle factors, polymorphisms in adiponectin, perilipin and hormone sensitive lipase, and clinical markers in Japanese males.	PLIN4 LIPE	6.03e-05	4	111	2	20495294
Pubmed	mRNA expression profile of multidrug-resistant genes in acute lymphoblastic leukemia of children, a prognostic value for ABCA3 and ABCA2.	ABCC1 ABCA3	6.03e-05	4	111	2	24145140
Pubmed	Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition.	CREBBP ASCL1	6.03e-05	4	111	2	30181244
Pubmed	The basic helix-loop-helix factor Hand 2 regulates autonomic nervous system development.	CREBBP ASCL1	6.03e-05	4	111	2	16145670
Pubmed	Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development.	MED8 CREBBP ARID1B YTHDF2	6.08e-05	66	111	4	23275444
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	DAB2IP ABCC1 DSC3 ITGA4 ADD1 GFOD2 PI4KA ITSN2	6.43e-05	421	111	8	36976175
Pubmed	Neuropathy-causing mutations in HSPB1 impair autophagy by disturbing the formation of SQSTM1/p62 bodies.	RUVBL2 MSH6 ATP2A2 NNT	6.45e-05	67	111	4	30669930
Pubmed	Expression of metanephric nephron-patterning genes in differentiating mesonephric tubules.	ITGA4 ADAM12 SLC18A1 ASCL1	7.24e-05	69	111	4	21491542
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	DSC3 DDX6 TMEM33 SERPINB9 AP2B1 PYGB PYGL PYGM NOP2 YTHDF2 DYNC1H1	8.42e-05	844	111	11	25963833
Pubmed	Defining the membrane proteome of NK cells.	ABCC1 CYP51A1 ITGA4 ADCY3 DDX6 SERPINB9 AP2B1 PI4KA PYGB LSS NNT DYNC1H1 KIFC1	9.24e-05	1168	111	13	19946888
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	DSC3 RUVBL2 ADD1 DDX6 TMEM33 ARFGAP2 ATP2A2 YTHDF2 DYNC1H1 CNN3	9.33e-05	708	111	10	39231216
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	EML6 CREBBP GLYR1 SLC49A4 NOP2 SLC4A5 DYNC1H1	9.85e-05	332	111	7	37433992
Pubmed	Hypoxic adaptation engages the CBP/CREST-induced coactivator complex of Creb-HIF-1α in transactivating murine neuroblastic glucose transporter.	SLC2A14 CREBBP	1.00e-04	5	111	2	23321477
Pubmed	Acetylation of MLH1 by CBP increases cellular DNA mismatch repair activity.	CREBBP MSH6	1.00e-04	5	111	2	37094360
Pubmed	ABC gene expression profiles have clinical importance and possibly form a new hallmark of cancer.	ABCA3 ABCA8	1.00e-04	5	111	2	28468577
Pubmed	Characterising the dynamics of placental glycogen stores in the mouse.	PYGB PYGL PYGM	1.09e-04	29	111	3	32798765
Pubmed	The Catalytically Inactive Mutation of the Ubiquitin-Conjugating Enzyme CDC34 Affects its Stability and Cell Proliferation.	TMEM33 MSH6 CPSF1 ATP2A2 DYNC1H1 KIFC1	1.17e-04	237	111	6	29564676
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	DAB2IP ABCC1 RELCH DSC3 NBEA PPM1H MSH6 ARID1B PI4KA GLYR1 CPSF1 ATP2A2	1.36e-04	1049	111	12	27880917
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	POLR1A RUVBL2 MSH6 AP2B1 GLYR1 PYGL ATP2A2 YTHDF2 DYNC1H1	1.37e-04	601	111	9	33658012
Pubmed	SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB.	RUVBL2 DDX6 AP2B1 CPSF1 PYGB PYGL ATP2A2 NNT YTHDF2	1.48e-04	607	111	9	39147351
Pubmed	Golgi associated RAB2 interactor protein family contributes to murine male fertility to various extents by assuring correct morphogenesis of sperm heads.	GARIN4 GARIN3	1.50e-04	6	111	2	38935810
Pubmed	Alternative neural crest cell fates are instructively promoted by TGFbeta superfamily members.	ASCL1 CNN1	1.50e-04	6	111	2	8616889
Pubmed	Calponin-3 deficiency augments contractile activity, plasticity, fibrogenic response and Yap/Taz transcriptional activation in lens epithelial cells and explants.	CNN1 CNN3	1.50e-04	6	111	2	31992794
Pubmed	Ca2+ -dependent interaction of S100A1 with the sarcoplasmic reticulum Ca2+ -ATPase2a and phospholamban in the human heart.	PYGM ATP2A2	1.50e-04	6	111	2	12804600
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	ABCC1 RUVBL2 CREBBP ARFGAP2 PI4KA GLYR1 CPSF1 NOP2 DYNC1H1 ALPL	1.56e-04	754	111	10	35906200
Pubmed	Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations.	CYP51A1 CREBBP ADD1 GK LIPE LSS	1.57e-04	250	111	6	18660489
Pubmed	Integration-independent Transgenic Huntington Disease Fragment Mouse Models Reveal Distinct Phenotypes and Life Span in Vivo.	AP2B1 ATP2A2 DYNC1H1	1.61e-04	33	111	3	26025364
Pubmed	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	DAB2IP EBF1 ADAMTS18 ALPL	1.63e-04	85	111	4	23648065
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	PCLO SLC2A14 ADD1 AP2B1 PYGB PYGL PYGM ATP2A2 DYNC1H1	1.75e-04	621	111	9	22794259
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CYP51A1 CHD9 RUVBL2 DDX6 TMEM33 MSH6 ARID1B AP2B1 GLYR1 CPSF1 ATP2A2 DYNC1H1	1.80e-04	1082	111	12	38697112
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	PCLO SLC2A14 NBEA ADD1 DDX6 TMEM33 ITPKB AP2B1 PI4KA ITSN2 TAGLN3 PYGB ATP2A2 DYNC1H1	1.89e-04	1431	111	14	37142655
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	ADD1 MSH6 ARFGAP2 AP2B1 YTHDF2 DYNC1H1 CNN3	1.92e-04	370	111	7	22922362
Pubmed	USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c.	MSH6 PYGB ATP2A2 DYNC1H1	2.03e-04	90	111	4	35654790
Pubmed	A protein interaction landscape of breast cancer.	ABCC1 MSH6 ARID1B SERPINB9 AP2B1 PI4KA LSS NOP2 NNT	2.04e-04	634	111	9	34591612
Pubmed	Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1.	EBF1 ATP2A2	2.10e-04	7	111	2	24786561
Pubmed	Large scale screening for novel rab effectors reveals unexpected broad Rab binding specificity.	GARIN4 GARIN3	2.10e-04	7	111	2	18256213
Pubmed	Repression of RNA polymerase I upon stress is caused by inhibition of RNA-dependent deacetylation of PAF53 by SIRT7.	POLR1A CREBBP	2.10e-04	7	111	2	24207024
Pubmed	Pokemon (FBI-1) interacts with Smad4 to repress TGF-β-induced transcriptional responses.	CREBBP ZBTB7A	2.10e-04	7	111	2	25514493
Pubmed	Synergistic activation of steroidogenic acute regulatory protein expression and steroid biosynthesis by retinoids: involvement of cAMP/PKA signaling.	CREBBP LIPE	2.10e-04	7	111	2	24265455
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	ABCC11 PABPC5 RUVBL2 TMEM33 PYGB PYGL ATP2A2 YTHDF2 DYNC1H1	2.37e-04	647	111	9	26618866
Pubmed	MTG8 interacts with LHX6 to specify cortical interneuron subtype identity.	SOX6 EBF1 ASCL1	2.66e-04	39	111	3	36064547
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	PCLO RUVBL2 DDX6 MSH6 ARID1B AP2B1 PYGB ATP2A2 NNT DYNC1H1	2.68e-04	807	111	10	30575818
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	KCTD9 CNOT11 CHD9 RUVBL2 DDX6 MSH6 ANAPC1 NOP2 DYNC1H1 KIFC1	2.73e-04	809	111	10	32129710
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	DAB2IP RELCH PCLO ADGRB3 NBEA RUVBL2 TMEM33 ARFGAP2 PI4KA GLYR1 PYGB ATP2A2	2.88e-04	1139	111	12	36417873
Pubmed	Insights into specificity, redundancy and new cellular functions of C/EBPa and C/EBPb transcription factors through interactome network analysis.	RUVBL2 SLC44A5 CPSF1 NOP2	2.93e-04	99	111	4	27746211
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	PCLO RREB1 CREBBP ARFGAP2 ARID1B PYGL LSS	2.98e-04	398	111	7	35016035
Pubmed	RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma.	POLR1A RUVBL2 MSH6 NOP2 KIFC1	3.12e-04	183	111	5	28186131
Pubmed	Proteomic Analysis of the Spinophilin Interactome in Rodent Striatum Following Psychostimulant Sensitization.	SLC2A14 ADD1 AP2B1 TAGLN3 PYGB ATP2A2 DYNC1H1	3.22e-04	403	111	7	30562941
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	CYP51A1 DLGAP5 RUVBL2 DDX6 TMEM33 MSH6 GLYR1 NOP2 ATP2A2 CNN3 KIFC1	3.31e-04	989	111	11	36424410
Pubmed	Identification of novel germline polymorphisms governing capecitabine sensitivity.	SOX6 SLC44A5	3.58e-04	9	111	2	22864933
Pubmed	Diverse Targets of β-Catenin during the Epithelial-Mesenchymal Transition Define Cancer Stem Cells and Predict Disease Relapse.	ABCC1 ABCC11	3.58e-04	9	111	2	26122848
Pubmed	Human lysophosphatidylcholine acyltransferases 1 and 2 are located in lipid droplets where they catalyze the formation of phosphatidylcholine.	PLIN4 LSS	3.58e-04	9	111	2	21498505
Pubmed	Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells.	CNOT11 DDX6 ATP2A2 YTHDF2	3.94e-04	107	111	4	30995489
Pubmed	An approach based on a genome-wide association study reveals candidate loci for narcolepsy.	PCLO ADGRB3 CELF2 SLC18A1 DYNC1H1	3.98e-04	193	111	5	20677014
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	KCTD9 POLR1A MED8 CHD9 RUVBL2 CREBBP MSH6 ANAPC1 CPSF1 PYGB PYGL	4.08e-04	1014	111	11	32416067
Pubmed	Huntingtin interacting proteins are genetic modifiers of neurodegeneration.	PLIN4 CREBBP DYNC1H1 ALPL CA4	4.37e-04	197	111	5	17500595
GeneFamily	Glycogen phosphorylases	PYGB PYGL PYGM	8.03e-08	3	79	3	437
GeneFamily	CD molecules\|Type II classical cadherins	CDH24 CDH10	1.43e-03	13	79	2	1186
GeneFamily	ATP binding cassette subfamily C	ABCC1 ABCC11	1.43e-03	13	79	2	807
GeneFamily	ATP binding cassette subfamily A	ABCA3 ABCA8	1.66e-03	14	79	2	805
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ITGA4 IFI27 DDX6 ANKRD44 ARID1B CELF2 ITSN2 DYNC1H1	3.95e-08	200	111	8	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	ADGRB3 CHD9 EBF1 ABCA8 ANKRD44 ARID1B CELF2	5.99e-07	195	111	7	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	RA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ABCC1 ADGRB3 EBF1 ABCA8 ANKRD44 ARID1B CELF2	6.20e-07	196	111	7	e8cbda03837f1f26470a9d93aa7fdaa04e08e38a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 MCF2 EBF1 ADAM12 ADCY3 PYGL	4.65e-06	172	111	6	08a3fe536b1b064c5ee7779bc2b1115a5963a26b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 MCF2 EBF1 ADAM12 ADCY3 PYGL	4.65e-06	172	111	6	553701349444eb366df3c11f54bb093434f153c6
ToppCell	10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MXRA5 ADGRB3 PABPC5 ADAM12 CNN3 ALPL	5.66e-06	178	111	6	8f31b3fac51591f7f2bcb898c07708b3e9f93a16
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CARMIL3 EBF1 ADAM12 ADAMTS18 SEPTIN12 CA4	6.63e-06	183	111	6	bc24145855bf4d027a8058bf92bc796c10f241bb
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CARMIL3 EBF1 ADAM12 ADAMTS18 SEPTIN12 CA4	6.63e-06	183	111	6	4c325ee6da070513097a11445ec95b0415ffd8a2
ToppCell	5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CARMIL3 THBS3 CDH24 ASCL1 TAGLN3 SLC4A5	7.05e-06	185	111	6	ef996f4cdbc3971c6c0460d13df64b075ab22154
ToppCell	MS-matDC\|MS / Condition, Cell_class and T cell subcluster	PLIN4 ADGRB3 MCF2 HMSD CNN1 CNN3	7.05e-06	185	111	6	46bd897349598d85e718e25f9a045d2247723c61
ToppCell	MS-matDC-\|MS / Condition, Cell_class and T cell subcluster	PLIN4 ADGRB3 MCF2 HMSD CNN1 CNN3	7.05e-06	185	111	6	9fbe70d3a7b106fb31e13b7f95029785f28ca6f4
ToppCell	5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CARMIL3 THBS3 CDH24 ASCL1 TAGLN3 SLC4A5	7.05e-06	185	111	6	d51342a3979bd728a80e04126059a3fd8a0dbe3b
ToppCell	LV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	ADGRB3 CHD9 EBF1 ABCA8 ANKRD44 CELF2	8.21e-06	190	111	6	12992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCLO TMEM215 ADAM12 ITPKB HSPA13 ATP2A2	8.46e-06	191	111	6	f76f3f5c7902a3659d8cbe470f96ce57c8a6744d
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ADGRB3 CHD9 EBF1 ABCA8 ANKRD44 CELF2	8.46e-06	191	111	6	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Slc30a3_(Deep_layer_pyramidal_cells)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	NLRP12 C3orf20 KRT24 SLC18A1	8.67e-06	52	111	4	106dd69be38d8ebd298d825c14ac0eefd8366a1a
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Slc30a3_(Deep_layer_pyramidal_cells)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	NLRP12 C3orf20 KRT24 SLC18A1	8.67e-06	52	111	4	9eaf9c1276a3e074cf6c476a419546cbbe4d525c
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCLO TMEM215 ADAM12 ITPKB HSPA13 ATP2A2	8.72e-06	192	111	6	5b7093d5af5ae7b0e6d3a464cc56272440ecedad
ToppCell	5'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAM12 ABCA8 ASCL1 TAGLN3 CNN3 ALPL	8.72e-06	192	111	6	3fc7a661ef39286abfd82ed8ab580011f01cb8fd
ToppCell	5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ITGA4 ADAM12 ABCA8 ASCL1 CNN3 ALPL	8.98e-06	193	111	6	4f4f430d7e1b65e19ca829f55ca93edeb6c1c85d
ToppCell	LV-01._Fibroblast_I\|LV / Chamber and Cluster_Paper	ADGRB3 CHD9 EBF1 ABCA8 ANKRD44 CELF2	8.98e-06	193	111	6	dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	ADGRB3 CHD9 EBF1 ABCA8 ANKRD44 CELF2	9.25e-06	194	111	6	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	ADGRB3 CHD9 EBF1 ABCA8 ANKRD44 CELF2	9.25e-06	194	111	6	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CARMIL3 PCLO NBEA TMEM215 ATP2A2 DYNC1H1	9.52e-06	195	111	6	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CARMIL3 PCLO NBEA TMEM215 ATP2A2 DYNC1H1	9.52e-06	195	111	6	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL7A1 DSC3 DLGAP5 KRT24 PYGB ATP2A2	1.01e-05	197	111	6	fb272c9c60ee3d980e528044dc567b4925a23da6
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCLO EML6 ADGRB3 NBEA SLC44A5 CELF2	1.04e-05	198	111	6	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ITGA4 ADAM12 ABCA8 CELF2 ASCL1 CNN3	1.04e-05	198	111	6	c8272ac4d90f2367f538f66db40de911ad73ea7f
ToppCell	ILEUM-inflamed-(8)_Activated_fibroblasts\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	COL7A1 MXRA5 IFI27 CNN1 CNN3 ALPL	1.07e-05	199	111	6	317f412996d463ddf2e6a52ff41d5d676c77f43f
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCLO ADGRB3 ABCA8 ASCL1 TAGLN3 PYGB	1.07e-05	199	111	6	47466253069d4b1b8f13ce3210f434e60753b38a
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	POLR1A SLC2A14 ABCC11 SERPINB9 DNAH17	4.34e-05	155	111	5	77ae0b8d30bc3db4a73fd5340f99691a73d2684f
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MXRA5 EBF1 ADAM12 ADAMTS18 CA4	4.76e-05	158	111	5	32c95c1bc9e50fccd6d06e828f29258fc5e568cb
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NBEA ITGA4 ADAM12 SLC44A5 CA4	5.20e-05	161	111	5	3b5d7a3dab479c6959a428f3954dedd989900276
ToppCell	Mild-MAIT\|Mild / Disease group and Cell class	DAB2IP TRAV1-2 TRAV1-1 ADAM12 EFCAB8	5.20e-05	161	111	5	0c1a04485708d5302600cdc2d7dac1cb76b4033a
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLIN4 EBF1 ABCA8 LIPE CELF2	5.20e-05	161	111	5	4f25eeabb841b0b9204cdd4e71d5e131e7868184
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLIN4 EBF1 ABCA8 LIPE CELF2	5.20e-05	161	111	5	a006491c991e6a134be20ad75092a91f3b7c3c91
ToppCell	Bronchial_Biopsy-Immune-Neutrophils\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	ITPKB SLC44A5 SLC18A1 GALNT11 PYGL	5.36e-05	162	111	5	985adca17b0c99563feef7910f3da5df31e636b6
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 MCF2 EBF1 ADCY3 SLC18A1	5.68e-05	164	111	5	43630a448f4369fa9e4e3eccdf3b9f29cec16c39
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MCF2 EBF1 ADAM12 ADCY3 PYGL	5.68e-05	164	111	5	b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 MCF2 EBF1 ADCY3 SLC18A1	5.68e-05	164	111	5	108fbecb56d69a675d6ce6e826a873ae528f2fd7
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 MCF2 EBF1 ADCY3 SLC18A1	5.68e-05	164	111	5	46208f18325976c89f572f6627aea0582142b92d
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	POLR1A ADGRB3 ABCA8 ASCL1 PYGL	6.19e-05	167	111	5	17c653b46507c8bb85da95836ae72a6015336142
ToppCell	droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l34\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RASGRP4 IFI27L2 DLGAP5 ITGA4 KIFC1	6.37e-05	168	111	5	84977db9d71e59208727885320cc18d80d064380
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PLIN4 PCLO ABCC11 PABPC5 CNN3	6.37e-05	168	111	5	435ef2e4d702e978d54f9d1f5a047f39c691cc63
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MCF2 NBEA EBF1 ADAM12 ADCY3	6.73e-05	170	111	5	876b84740e15399bfff2b9c7f0b80fd759bbdb3f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MCF2 NBEA EBF1 ADAM12 ADCY3	6.73e-05	170	111	5	1f8738acf439d893880db7e1fdc9b3615ca00c39
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL7A1 EBF1 ADAMTS18 CNN1 CA4	6.92e-05	171	111	5	a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34
ToppCell	E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EML6 ADGRB3 ASCL1 DNAH17 TAGLN3	7.52e-05	174	111	5	742c73c9e090848b464323cb17579b86658c6792
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPR137 PABPC5 ADCY3 TAGLN3 CNN1	7.52e-05	174	111	5	c529f3674b784f872f4387ffdeb46aecb619976b
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_4\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	DAB2IP ABCA3 CNN3 ACOXL ALPL	7.52e-05	174	111	5	110369f6b78de34a6d934b5b47cecd023347bc80
ToppCell	E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EML6 ADGRB3 ASCL1 DNAH17 TAGLN3	7.52e-05	174	111	5	7fed9722e64c60843092f2ba71256e3043011ef6
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DAB2IP ADGRB3 EBF1 ITGA4 ADCY3	7.52e-05	174	111	5	015d3742d3d79a57413a333f00ef2d380a9848dd
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PCDHGA1 PABPC5 ANKRD44 ASCL1	7.61e-05	90	111	4	3817a5b0235e632d976ea565175bdbebbd959bf0
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PCDHGA1 PABPC5 ANKRD44 ASCL1	7.61e-05	90	111	4	a528f5dcee1a356dea89ff2588d2e0f276f2d5fc
ToppCell	390C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|390C / Donor, Lineage, Cell class and subclass (all cells)	MXRA5 ADGRB3 PABPC5 GARIN4 SLC4A5	7.93e-05	176	111	5	852d3da0907fe87c0ef23d75a63ce07619cf0c54
ToppCell	390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	MXRA5 ADGRB3 PABPC5 GARIN4 SLC4A5	7.93e-05	176	111	5	d2df1e435996c51213e88270af9f928e9e09a6f5
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL7A1 GXYLT2 THBS3 CNN1 ALPL	8.37e-05	178	111	5	27497dbfcf9bb4dd0bf7caa0bd78c7e85f5c18ee
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL7A1 GXYLT2 THBS3 CNN1 ALPL	8.37e-05	178	111	5	d348a9550db940d204706529759dc51e30506b5f
ToppCell	LA-01._Fibroblast_I\|LA / Chamber and Cluster_Paper	ADGRB3 CHD9 EBF1 ABCA8 CELF2	8.59e-05	179	111	5	dcb6ec9ae72b13fe388b72dace2815293fafe8ee
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MXRA5 EBF1 ADAM12 ADAMTS18 CA4	8.82e-05	180	111	5	64956a85c404a2ea7e4eaf6f95ebcc52c198b7cc
ToppCell	PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GPR137 ABCC1 RASGRP4 NLRP12 SERPINB9	9.05e-05	181	111	5	2b9b460239d67fd480cee60820cdb306109d3567
ToppCell	droplet-Marrow-BM-1m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IFI27L2 EBF1 NNT CNN3 ALPL	9.05e-05	181	111	5	89c551de26de047c316c91ac1d97bdf728a33d9e
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2\|TCGA-Skin / Sample_Type by Project: Shred V9	CYP51A1 PPM1H ITPKB AP2B1 DYNC1H1	9.05e-05	181	111	5	9d5b331cabc5524f0a9fd8b571e87be4c447c7d4
ToppCell	PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	GPR137 ABCC1 RASGRP4 NLRP12 SERPINB9	9.05e-05	181	111	5	2a1aa4a0ec7bc367857beaff543135e4345c835b
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IFI27L2 CHD9 EBF1 ITGA4 ITSN2	9.29e-05	182	111	5	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA3 GK SLC18A1 GALNT11 ALPL	9.29e-05	182	111	5	faf0dfa3adc2d2706b6942b5127093ccdc856447
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA3 GK SLC18A1 GALNT11 ALPL	9.29e-05	182	111	5	be8dd52898525ce6632af0adc2801944f3ac10bd
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD9 EBF1 ITGA4 DDX6 ITSN2	9.29e-05	182	111	5	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EBF1 TMEM215 ITGA4 ADCY3 CNN1	9.53e-05	183	111	5	4060d979948e1dd7507977629a7fbdfa4ca65bb6
ToppCell	PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	GPR39 PPM1H SLC44A5 ASCL1 ALPL	9.53e-05	183	111	5	c5b10571599dc26476170b54b53f09c23e6b3117
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EBF1 TMEM215 ITGA4 ADCY3 CNN1	9.53e-05	183	111	5	0d44a978221cf3f733704bf11863502805fba733
ToppCell	normal_Lung-Fibroblasts-Myofibroblasts\|normal_Lung / Location, Cell class and cell subclass	COL7A1 MXRA5 TMEM215 ADAM12 CNN1	9.78e-05	184	111	5	0b336489c10e8c3c957795dd845454f03404382b
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3\|TCGA-Lung / Sample_Type by Project: Shred V9	ABCC1 COL7A1 DSC3 ADCY3 MSH6	9.78e-05	184	111	5	ea4ccebe2d54279fcc517e4f0bfa652b91a808bb
ToppCell	5'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-Neuroblast\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAM12 SLC18A1 ASCL1 TAGLN3 ALPL	9.78e-05	184	111	5	7aa245b73e10fd73d292e822de6b72920aa12355
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IFI27L2 CHD9 ITGA4 DDX6 ITSN2	9.78e-05	184	111	5	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	droplet-Marrow-BM-1m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IFI27L2 EBF1 NNT CNN3 ALPL	9.78e-05	184	111	5	69348c9237e44f7752ac01f60e733ad41580fdb8
ToppCell	droplet-Kidney-nan-3m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA3 GK SLC18A1 GALNT11 ALPL	1.00e-04	185	111	5	3e3217c99719fd1d2fa94e16be7712a7e5077152
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SOX6 ADGRB3 EBF1 ABCA8 GXYLT2	1.00e-04	185	111	5	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	droplet-Kidney-nan-3m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA3 GK SLC18A1 GALNT11 ALPL	1.00e-04	185	111	5	0ff4148b4701003d9d594e0da8261176fb13aa59
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IFI27L2 CHD9 EBF1 ITGA4 ITSN2	1.00e-04	185	111	5	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	5'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ITGA4 ADAM12 ASCL1 CNN3 ALPL	1.00e-04	185	111	5	0149981d3818a6250f32c08456c28e7037c39d91
ToppCell	Control-Myeloid-DC_Mature\|Myeloid / Disease state, Lineage and Cell class	EBF1 ITGA4 ADAM12 HMSD SERPINB9	1.03e-04	186	111	5	e9e58c5871b4966cd3586b611703e21af8df6360
ToppCell	(101)_plasma\|World / immune cells in Peripheral Blood (logTPM normalization)	DLGAP5 EML6 OXCT2 HSPA13 IFI27L1	1.03e-04	186	111	5	16267994c9ef1fb7118c4c665cbc96979ec2b703
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	CYP51A1 ITGA4 HSPA13 ANKRD44 MSH6	1.03e-04	186	111	5	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	LA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	ADGRB3 CHD9 EBF1 ABCA8 CELF2	1.05e-04	187	111	5	4ea486991f66c29728d127171a07b81404ec0b78
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 MCF2 EBF1 ADAM12 ADCY3	1.05e-04	187	111	5	15d6e158562d7d85af3ceaf955439b379c8fce81
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 MCF2 EBF1 ADAM12 ADCY3	1.05e-04	187	111	5	f62074b631fd45ad299c69d71b09267b04d656ee
ToppCell	mild_COVID-19-Plasmablast\|World / disease group, cell group and cell class (v2)	DLGAP5 OXCT2 IFI27L1 ACOXL KIFC1	1.08e-04	188	111	5	9a5ba6abdc307402301dae25db2a5f3e0d576417
ToppCell	severe_COVID-19-Plasmablast\|World / disease group, cell group and cell class (v2)	DLGAP5 OXCT2 IFI27L1 ACOXL KIFC1	1.08e-04	188	111	5	25ca19af4ac419a0f5026a6ccbd8b554b268a6f3
ToppCell	human_hepatoblastoma-NK.T_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	TRAV1-1 ITGA4 ITPKB ANKRD44 CELF2	1.08e-04	188	111	5	71b7599e7e1d63cc0c8518c0501533755951d58f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 MCF2 EBF1 ADAM12 ADCY3	1.08e-04	188	111	5	32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081
ToppCell	droplet-Spleen-nan-3m-Lymphocytic-B_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IFI27L2 EBF1 ITSN2 C19orf44 CNN3	1.08e-04	188	111	5	8b1485e63cd4020ba5334a8d4b84725b164549bf
ToppCell	21-Trachea-Epithelial-Neuroendocrine\|Trachea / Age, Tissue, Lineage and Cell class	PCLO SLC18A1 ASCL1 TAGLN3 PYGM	1.08e-04	188	111	5	e78d4f7a5d28c77503cb041ff585d13df4c88bd2
ToppCell	Children_(3_yrs)-Immune-T_lymphocyte-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ABCC1 ITGA4 ITPKB ANKRD44 CELF2	1.11e-04	189	111	5	df30478b288084a1bd48f660409dcc784040897c
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DLGAP5 NBEA ASCL1 TAGLN3 KIFC1	1.11e-04	189	111	5	815afad947ed77a8b03724bf78014799fed34f54
ToppCell	severe_COVID-19-Plasmablast\|severe_COVID-19 / disease group, cell group and cell class (v2)	DLGAP5 OXCT2 IFI27L1 ACOXL KIFC1	1.11e-04	189	111	5	953143b2c2e87a4d8ef033a5fbb155fe62e9c78e
ToppCell	tumor_Lung-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	EBF1 ITGA4 IFI27 ADCY3 CA4	1.11e-04	189	111	5	9c407b17d7945e81e1ae6c18452f5d20fb09d563
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	GPR39 PCLO PPM1H SLC44A5 CDH10	1.11e-04	189	111	5	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RASGRP4 GK PYGL ALPL CA4	1.11e-04	189	111	5	235c24eeab5139f5821fccd5c879d8787682f4ef
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	CYP51A1 ITGA4 HSPA13 ANKRD44 CELF2	1.16e-04	191	111	5	9454f642c3621370fa23640b631301346b300950
Drug	6-FPLP	OXCT2 PYGB PYGL PYGM	2.39e-09	5	108	4	CID000146246
Drug	6-FDPL	OXCT2 PYGB PYGL PYGM	2.39e-09	5	108	4	CID000129578
Drug	6-fluoropyridoxal	OXCT2 PYGB PYGL PYGM	1.66e-08	7	108	4	CID003080803
Drug	8-azidoadenosine 5'-monophosphate	PYGB PYGL PYGM NNT	9.84e-08	10	108	4	CID000124726
Drug	3,5-dimethylphenyl isocyanate	PYGB PYGL PYGM	1.04e-07	3	108	3	CID000521488
Drug	5'-deoxy-5'-fluoro-5'-(methylthio)adenosine	PYGB PYGL PYGM	1.04e-07	3	108	3	CID000147839
Drug	NSC758405	PYGB PYGL PYGM	1.04e-07	3	108	3	CID000003201
Drug	3,5-dinitrophenyl phosphate	PYGB PYGL PYGM	1.04e-07	3	108	3	CID000151920
Drug	pyridoxal phosphoglucose	PYGB PYGL PYGM	1.04e-07	3	108	3	CID000196007
Drug	5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone	PYGB PYGL PYGM	1.04e-07	3	108	3	CID000093111
Drug	adenosine-5'-chloromethylphosphonate	PYGB PYGL PYGM	1.04e-07	3	108	3	CID000191554
Drug	hydan	PYGB PYGL PYGM	1.04e-07	3	108	3	CID000008360
Drug	EHMF	PYGB PYGL PYGM	1.04e-07	3	108	3	CID000033931
Drug	pyridoxal 5'-methylenephosphonate	PYGB PYGL PYGM	1.04e-07	3	108	3	CID003082249
Drug	Plp 5'-mpa	PYGB PYGL PYGM	1.04e-07	3	108	3	CID003082151
Drug	glucose-1,2-cyclic phosphate	PYGB PYGL PYGM	1.04e-07	3	108	3	CID000191723
Drug	3'-FFdUrd	PYGB PYGL PYGM	1.04e-07	3	108	3	CID000072260
Drug	2',3',4',5,5'-pentachloro-2-biphenylol	PYGB PYGL PYGM	1.04e-07	3	108	3	CID000119518
Drug	AC1L8XK3	PYGB PYGL PYGM	1.04e-07	3	108	3	CID000409735
Drug	N-acetyl-N'-beta-D-glucopyranosyl urea	PYGB PYGL PYGM	1.04e-07	3	108	3	CID000446801
Drug	riboflavin tetraacetate	PYGB PYGL PYGM	1.04e-07	3	108	3	CID000094186
Drug	2,5-dimethyl-3-furanone	PYGB PYGL PYGM	1.04e-07	3	108	3	CID000085730
Drug	3,5-dinitrophenol	PYGB PYGL PYGM	1.04e-07	3	108	3	CID000011459
Drug	5'-deoxypyridoxal	OXCT2 PYGB PYGL PYGM	2.30e-07	12	108	4	CID000164889
Drug	galocitabine	PYGB PYGL PYGM	4.14e-07	4	108	3	CID000065950
Drug	5-deoxyribose-1-phosphate	PYGB PYGL PYGM	4.14e-07	4	108	3	CID000135786
Drug	ingliforib	PYGB PYGL PYGM	4.14e-07	4	108	3	CID006451325
Drug	uric acid riboside	PYGB PYGL PYGM	4.14e-07	4	108	3	CID000164933
Drug	pseudo-dl-glucose	PYGB PYGL PYGM	4.14e-07	4	108	3	CID000125259
Drug	pyridoxal diphosphate	PYGB PYGL PYGM	4.14e-07	4	108	3	CID000125696
Drug	2,5-anhydro-D-mannitol 1-phosphate	PYGB PYGL PYGM	4.14e-07	4	108	3	CID000189134
Drug	AC1LAMW2	PYGB PYGL PYGM	4.14e-07	4	108	3	CID000491364
Drug	FdUrd-C8	PYGB PYGL PYGM	4.14e-07	4	108	3	CID000094262
Drug	Mem-CC	PYGB PYGL PYGM	4.14e-07	4	108	3	CID003081269
Drug	BCIp4A	PYGB PYGL PYGM	4.14e-07	4	108	3	CID000192417
Drug	3'-chloromethotrexate	PYGB PYGL PYGM	4.14e-07	4	108	3	CID000097703
Drug	heptulose-2-P	PYGB PYGL PYGM	1.03e-06	5	108	3	CID000124823
Drug	gluconohydroximo-1,5-lactone	PYGB PYGL PYGM	1.03e-06	5	108	3	CID009576855
Drug	DHPBU	PYGB PYGL PYGM	1.03e-06	5	108	3	CID000125914
Drug	5'-isobutylthioinosine	PYGB PYGL PYGM	1.03e-06	5	108	3	CID003080910
Drug	indirubin-5-sulphonate	PYGB PYGL PYGM	1.03e-06	5	108	3	CID005288641
Drug	AC1LCUXJ	PYGB PYGL PYGM	1.03e-06	5	108	3	CID000656425
Drug	6-amino-5-bromouracil	PYGB PYGL PYGM	1.03e-06	5	108	3	CID000080578
Drug	etafenone	PYGB PYGL PYGM	1.03e-06	5	108	3	CID000003275
Drug	ddEtUrd	PYGB PYGL PYGM	1.03e-06	5	108	3	CID000451452
Drug	5-trifluoromethyl-2'-deoxycytidine	PYGB PYGL PYGM	1.03e-06	5	108	3	CID000125618
Drug	m-anisidine	PYGB PYGL PYGM	1.03e-06	5	108	3	CID000010824
Drug	2-hydroxypropylphosphonate	PYGB PYGL PYGM	1.03e-06	5	108	3	CID000441028
Drug	3'-O-methylpyridoxal 5'-phosphate	PYGB PYGL PYGM	1.03e-06	5	108	3	CID003082179
Drug	GlcMan	PYGB PYGL PYGM	1.03e-06	5	108	3	CID000152120
Drug	U66985	PYGB PYGL PYGM	1.03e-06	5	108	3	CID000127224
Drug	AC1O3M08	PYGB PYGL PYGM	1.03e-06	5	108	3	CID006331955
Drug	CV-araU	PYGB PYGL PYGM	2.05e-06	6	108	3	CID006441877
Drug	2-thiothymidine	PYGB PYGL PYGM	2.05e-06	6	108	3	CID003005944
Drug	Carbocyclic Bvdc	PYGB PYGL PYGM	2.05e-06	6	108	3	CID006438602
Drug	2,2-dimethyl-3-hydroxybutyric acid	PYGB PYGL PYGM	2.05e-06	6	108	3	CID000152984
Drug	EdUMP	PYGB PYGL PYGM	2.05e-06	6	108	3	CID003085112
Drug	5'-deoxy-5'-chloroformycin	PYGB PYGL PYGM	2.05e-06	6	108	3	CID000126430
Drug	5-n-propylthioadenosine	PYGB PYGL PYGM	2.05e-06	6	108	3	CID000656428
Drug	AzddCyd	PYGB PYGL PYGM	2.05e-06	6	108	3	CID000451374
Drug	5-Ffdru	PYGB PYGL PYGM	2.05e-06	6	108	3	CID000065561
Drug	Carbocyclic Ivdu	PYGB PYGL PYGM	2.05e-06	6	108	3	CID006439191
Drug	DNPP	PYGB PYGL PYGM	2.05e-06	6	108	3	CID000067056
Drug	5-chloro-indole-2-carboxylic acid	PYGB PYGL PYGM	2.05e-06	6	108	3	CID000082693
Drug	NSC-97433	PYGB PYGL PYGM	2.05e-06	6	108	3	CID000001803
Drug	AR-L57	PYGB PYGL PYGM	2.05e-06	6	108	3	CID000156890
Drug	alpha-(fluoromethyl)dehydroornithine	PYGB PYGL PYGM	3.58e-06	7	108	3	CID006439607
Drug	AC1L3372	PYGB PYGL PYGM	3.58e-06	7	108	3	CID000108025
Drug	1 Gpt	PYGB PYGL PYGM	3.58e-06	7	108	3	CID000101247
Drug	formycins	PYGB PYGL PYGM	3.58e-06	7	108	3	CID000512867
Drug	5'-methylthioinosine	PYGB PYGL PYGM	3.58e-06	7	108	3	CID000161214
Drug	hydantocidin	PYGB PYGL PYGM	3.58e-06	7	108	3	CID000125429
Drug	2',3'-dideoxy-3'-fluorocytidine	PYGB PYGL PYGM	3.58e-06	7	108	3	CID000356019
Drug	heptenitol	PYGB PYGL PYGM	3.58e-06	7	108	3	CID000188267
Drug	Promonta	PYGB PYGL PYGM	3.58e-06	7	108	3	CID000108494
Drug	6-methylpurine	PYGB PYGL PYGM	5.71e-06	8	108	3	CID005287547
Drug	Etafenone [inn]	PYGB PYGL PYGM	5.71e-06	8	108	3	CID000066659
Drug	AC1NUVX5	PYGB PYGL PYGM	5.71e-06	8	108	3	CID005461894
Drug	amorphin	PYGB PYGL PYGM	5.71e-06	8	108	3	CID000122792
Drug	dihydroxyacetone	ADCY3 GK PYGB PYGL PYGM ALPL	7.32e-06	98	108	6	CID000000670
Drug	alpha-maltosyl fluoride	PYGB PYGL PYGM	8.54e-06	9	108	3	CID000194237
Drug	6-benzyl-2-thiouracil	PYGB PYGL PYGM	8.54e-06	9	108	3	CID000685814
Drug	5'-methylthiotubercidin	PYGB PYGL PYGM	8.54e-06	9	108	3	CID000188350
Drug	5-Iodoribose 1-phosphate	PYGB PYGL PYGM	8.54e-06	9	108	3	CID003035973
Drug	5'-iodo-5'-deoxyadenosine	PYGB PYGL PYGM	8.54e-06	9	108	3	CID000107502
Drug	pyrimidin	AGXT2 PYGB PYGL PYGM NOP2	8.93e-06	59	108	5	CID000009260
Drug	1-o-phosphonohex-2-ulose	ADCY3 PYGB PYGL PYGM	1.04e-05	29	108	4	CID000000481
Drug	6-methyluridine	PYGB PYGL PYGM	1.22e-05	10	108	3	CID000092887
Drug	UDP-pyridoxal	PYGB PYGL PYGM	1.22e-05	10	108	3	CID000126789
Drug	2,6-dihydroxypyridine	PYGB PYGL PYGM	1.22e-05	10	108	3	CID000069371
Drug	tungstate	ADCY3 PYGB PYGL PYGM ALPL CA4	1.28e-05	108	108	6	CID000001152
Drug	octopamine	OXCT2 ADCY3 SLC18A1 PYGB PYGL PYGM	1.35e-05	109	108	6	CID000004581
Drug	glucosyl fluoride	PYGB PYGL PYGM	1.67e-05	11	108	3	CID000150967
Drug	9 Da	PYGB PYGL PYGM	1.67e-05	11	108	3	CID005287565
Drug	Cid 11299980	PYGB PYGL PYGM	1.67e-05	11	108	3	CID009856533
Drug	2-deoxy-D-arabino-hexose 6-phosphate	OXCT2 GK PYGB PYGL	1.99e-05	34	108	4	CID000108108
Drug	BCX-34	PYGB PYGL PYGM	2.21e-05	12	108	3	CID000060817
Drug	Ap4U	PYGB PYGL PYGM	2.21e-05	12	108	3	CID000165888
Drug	phenylurethane	PYGB PYGL PYGM	2.21e-05	12	108	3	CID000007591
Drug	acyclothymidine	PYGB PYGL PYGM	2.21e-05	12	108	3	CID000072358
Disease	monocyte percentage of leukocytes	NLRP12 POLR1A CHD9 EBF1 ITGA4 ADD1 DDX6 ANKRD44 PI4KA ITSN2 ACOXL	6.59e-05	731	106	11	EFO_0007989
Disease	glycogen phosphorylase, liver form measurement	NLRP12 PYGL	7.63e-05	4	106	2	EFO_0801642
Disease	Cis-4-decenoyl carnitine measurement	ABCC1 SLC44A5	1.27e-04	5	106	2	EFO_0022091
Disease	decenoylcarnitine measurement	ABCC1 SLC44A5	1.27e-04	5	106	2	EFO_0021803
Disease	nonanoylcarnitine (C9) measurement	ABCC1 SLC44A5	1.90e-04	6	106	2	EFO_0800381
Disease	autism spectrum disorder (implicated_via_orthology)	ABCA3 CHD9 NBEA CREBBP ARID1B	2.26e-04	152	106	5	DOID:0060041 (implicated_via_orthology)
Disease	immature granulocyte measurement	NLRP12 ITGA4	2.65e-04	7	106	2	EFO_0803543
Disease	Disease Exacerbation	ABCC1 COL7A1 ABCC11 ARFGAP2 CPSF1	3.31e-04	165	106	5	C0235874
Disease	heart disease (implicated_via_orthology)	SOX6 LIPE ATP2A2	3.47e-04	38	106	3	DOID:114 (implicated_via_orthology)
Disease	cis-4-decenoylcarnitine (C10:1) measurement	ABCC1 SLC44A5	3.53e-04	8	106	2	EFO_0800311
Disease	asparaginase-induced acute pancreatitis	C3orf20 ADAMTS18	4.53e-04	9	106	2	EFO_1001507
Disease	octanoylcarnitine measurement	ABCC1 SLC44A5	4.53e-04	9	106	2	EFO_0021042
Disease	decanoylcarnitine measurement	ABCC1 SLC44A5	8.24e-04	12	106	2	EFO_0021039
Disease	glutaroyl carnitine measurement	ABCC1 SLC44A5	9.72e-04	13	106	2	EFO_0021005
Disease	Lymphoma, Follicular, Grade 2	EBF1 CREBBP	1.30e-03	15	106	2	C1956132
Disease	Lymphoma, Follicular, Grade 3	EBF1 CREBBP	1.30e-03	15	106	2	C1956131
Disease	Lymphoma, Follicular, Grade 1	EBF1 CREBBP	1.30e-03	15	106	2	C1956130
Disease	Lymphoma, Large-Cell, Follicular	EBF1 CREBBP	1.30e-03	15	106	2	C0079745
Disease	Lymphoma, Small Cleaved-Cell, Follicular	EBF1 CREBBP	1.30e-03	15	106	2	C0079765
Disease	Lymphoma, Mixed-Cell, Follicular	EBF1 CREBBP	1.30e-03	15	106	2	C0079758
Disease	migraine disorder, type 2 diabetes mellitus	EBF1 RREB1 ADD1	1.33e-03	60	106	3	MONDO_0005148, MONDO_0005277
Disease	dual specificity mitogen-activated protein kinase kinase 2 measurement	IFI27 IFI27L1	1.48e-03	16	106	2	EFO_0008112
Disease	galectin-3 measurement	NLRP12 DLGAP5	1.48e-03	16	106	2	EFO_0008137
Disease	Malignant neoplasm of breast	ABCC1 COL7A1 ABCA3 DSC3 ADAM12 MSH6 THBS3 ARID1B LIPE ITSN2 CDH10	1.68e-03	1074	106	11	C0006142
Disease	immature granulocyte count	NLRP12 ITGA4	1.68e-03	17	106	2	EFO_0803542
Disease	essential hypertension (is_implicated_in)	ADD1 ATP2A2	1.88e-03	18	106	2	DOID:10825 (is_implicated_in)
Disease	protein Z-dependent protease inhibitor measurement	IFI27 IFI27L1	1.88e-03	18	106	2	EFO_0021849
Disease	calcium measurement	GPR39 RREB1 ITPKB THBS3 ARID1B PYGB ATP2A2 ALPL	1.96e-03	628	106	8	EFO_0004838
Disease	testosterone measurement	SOX6 POLR1A EBF1 RREB1 RUVBL2 ABCA8 DDX6 MSH6 ARID1B LIPE ANAPC1 ASCL1	2.10e-03	1275	106	12	EFO_0004908
Disease	lymphocyte count	KCTD9 ABCC1 PCDHGA1 EML6 EBF1 ITGA4 RREB1 ZBTB7A SERPINB9 ANAPC1 DNAH17 C19orf44 ACOXL	2.28e-03	1464	106	13	EFO_0004587
Disease	cerebellum white matter volume change measurement, age at assessment	ADGRB3 ABCA8	2.33e-03	20	106	2	EFO_0008007, EFO_0021498
Disease	Lymphoma, Follicular	EBF1 CREBBP	2.33e-03	20	106	2	C0024301
Disease	erythrocyte measurement	SOX6 ITGA4 ZBTB7A AP2B1 ACOXL	2.39e-03	257	106	5	EFO_0005047
Disease	smoking status measurement, diastolic blood pressure	SOX6 EBF1 ARID1B ACOXL	2.63e-03	159	106	4	EFO_0006336, EFO_0006527

Protein segments in the cluster

Peptide	Gene	Start	Entry
VTMAKGIGNGFPMAA	AGXT2	346	Q9BYV1
MGGAKVMATTGGTNL	DDX6	191	P26196
SNLGAFSGIQQMAGM	CELF2	261	O95319
SSMQMGAVDLLGGGL	AP2B1	646	P63010
GQRMLAGDGMSQVTK	ADGRB3	586	O60242
MGKMAAAVGSVATLA	ALKBH1	1	Q13686
GNMGAMAVTLAQTLG	ADAM11	361	O75078
LNTAQAGGMAKMGIT	CREBBP	256	Q92793
SNVAMAMGAQLIGKF	ABCA3	411	Q99758
MAVEKGGCIMNASTG	ADAM12	371	O43184
GKMAVLANGVMNSLQ	ARFGAP2	501	Q8N6H7
QAAAGMGLGKDMGAQ	ARID1B	551	Q8NFD5
TLGNMMDKLANTQGE	C6orf163	246	Q5TEZ5
GEGAMGTAQLQIMAS	ARMCX4	661	Q5H9R4
VMNMVSGLFKDGTIG	ADAMTS18	321	Q8TE60
AVAFQAMGAMKLGLT	ACOXL	241	Q9NUZ1
MMGGFGGASIQKAQS	ITSN2	196	Q9NZM3
LSLAMVMAGSGNLKV	ANAPC1	1521	Q9H1A4
NKMGQLTTSGAMLAN	RELCH	1196	Q9P260
DLQMANGGKSLSMVD	DAB2IP	736	Q5VWQ8
IAAKMMSAAAIANGG	IFI27	66	P40305
KGVDMEGSQMTGINL	KCTD9	311	Q7L273
MQVLMKSQKGSLAGG	GPR39	246	O43194
KMMSAAAIANGGGVS	IFI27L2	41	Q9H2X8
GGMTSNKILMQLQAD	GK3P	426	Q14409
KGTSVCQAAAMGGAM	GPR137	211	Q96N19
GGNKGNMALAGTASM	GARIN4	321	Q8IYT1
LSGNGMEDIGAKMLS	CARMIL3	576	Q8ND23
NSLGGSAKMLMFVNI	KIFC1	626	Q9BW19
VIQAKDMGGHMGGLS	CDH24	226	Q86UP0
GNVMSMASVQLAGAK	CPSF1	76	Q10570
GSAEQTGKLMEGMQV	PCLO	4541	Q9Y6V0
KSPTMAGGLFAMNRQ	GALNT11	321	Q8NCW6
GLMGSGIVSNLLKMG	GLYR1	276	Q49A26
KVMASMNLGLLSEGG	RASGRP4	41	Q8TDF6
YGSAGVNSGVMLMNL	GXYLT2	261	A0PJZ3
MGLDGMKMQGTNGSQ	LSS	371	P48449
NLVVSKGMMLGVCGN	ABCC11	531	Q96J66
RSMSLNIGGAKGSMN	PI4KA	1326	P42356
EMKNMQGSSGGEVTV	KRT24	286	Q2M2I5
IAAKMMSTAAIANGG	IFI27L1	46	Q96BM0
SGKTALMMAAENGQA	ANKRD44	871	Q8N8A2
NMGGKSTLMRQAGLL	MSH6	1136	P52701
ADRSGKDGVMGMNSI	SLC2A14	496	Q8TDB8
KAQAIIATMGGTTLM	MAGEA13P	311	A6NCF6
GSISRAKVMMEVGQG	PABPC5	326	Q96DU9
AKNVIMFLGDGMGVS	ALPL	51	P05186
NMLFSGTNIAAGKAM	ATP2A2	206	P16615
TGLPSGGEAKNMAAM	CHD9	2696	Q3L8U1
MMLLENKASISGGGL	CA4	91	P22748
TMGSGMKNGGQETIE	DSC3	766	Q14574
MMKGGNQTLESCRGA	DSC3	781	Q14574
VMLVGNAGTGKSVLM	DNAH17	2451	Q9UFH2
MESSAKMESGGAGQQ	ASCL1	1	P50553
VIQAKDMGGQMGGLS	CDH10	236	Q9Y6N8
KVASMAAMGPALGGA	C19orf44	546	Q9H6X5
GQMLNGLAGPTVMNA	SLC49A4	151	Q96SL1
NSVVQGMILMFAGGK	C3orf20	776	Q8ND61
GQAMEKVTGGNLLSM	CYP51A1	21	Q16850
QMLMGGGVCSTVTLN	GFOD2	226	Q3B7J2
NATSGMNPDGVLSKM	DLGAP5	276	Q15398
DGGMTSNKILMQLQA	GK	431	P32189
NNFMLRIGMNKGGVL	ADCY3	1036	O60266
AGMMGVNSFSGQLAV	EBF1	431	Q9UH73
GNLNELGKMIMQGGF	MCF2	686	P10911
GSGAVMNAMETNLVG	ITGA4	346	P13612
NSTGALGMDAFIKAM	EFCAB8	66	A8MWE9
EVLSKFGQMLGSNMT	DYNC1H1	1126	Q14204
ALAMVFMGAKGNTAA	HMSD	6	A8MTL9
GTLTIGSKMMFQDGN	SLC44A5	191	Q8NCS7
QASGLNVVMLGMAGA	COL7A1	1181	Q02388
LNKQGGMFLTRAMSG	HSPA13	236	P48723
GMFLTRAMSGNNKLG	HSPA13	241	P48723
GAAKMQTMLSVAFGA	EML6	1551	Q6ZMW3
SPATMGGMVAQGVKL	LIPE	246	Q05469
LSGVQMAQAGQPGKM	MED8	236	Q96G25
SMEVQAQDGAGLMAK	PCDHGA1	316	Q9Y5H4
MENGMLVTDSAGKQL	ABCC1	896	P33527
ELLAQMSGAMALGGT	NNT	671	Q13423
KAQGGQELEMISGTM	GARIN3	576	Q8TC56
IQGGLDTTKSMVMGT	PLIN4	371	Q96Q06
GVTGAMSMAKGAVQG	PLIN4	986	Q96Q06
MSMAKGAVQGGLDTT	PLIN4	991	Q96Q06
TGKTAIAMGMAQALG	RUVBL2	81	Q9Y230
ENSLQMMVQSGAKGS	POLR1A	891	O95602
LQMGSNKGASQAGMT	TAGLN3	176	Q9UI15
LVIMNSANEMKSGGG	ITPKB	11	P27987
KSSVAMQEQMLGGKG	NBEA	536	Q8NFP9
GGKTSYMAQLMKNTG	NOP2	396	P46087
KVKGMGGAMDLVSSQ	OXCT2	416	Q9BYC2
GMKTDGGSLAGNEMI	SOX6	781	P35712
GKNMKMHSFIGQSGV	ABCA8	206	O94911
QGGMAALNMSLGMVT	ADD1	111	P35611
LQMGTNKGASQAGMT	CNN1	206	P51911
QMGSNKGASQRGMTV	CNN1	246	P51911
LQMGTNKGASQAGML	CNN3	206	Q15417
LMDVGNMGQSVDISG	CNOT11	206	Q9UKZ1
MFTVSGMKGETLGNI	TMEM215	26	Q68D42
GTEASGTGNMKFMLN	PYGM	671	P11217
GTGNMKFMLNGALTI	PYGM	676	P11217
KFMLNGALTIGTMDG	PYGM	681	P11217
MVLLGAKGNTATQMA	SERPINB9	41	P50453
KSAVANFMGGIMAGS	PPM1H	6	Q9ULR3
MSAVMSVGKVTENGG	RREB1	21	Q92766
NIMVVGQSGLGKSTM	SEPTIN12	51	Q8IYM1
GTEASGTGNMKFMLN	PYGB	671	P11216
GTGNMKFMLNGALTI	PYGB	676	P11216
KFMLNGALTIGTMDG	PYGB	681	P11216
LYMGVASLNGIQMGT	SLC4A5	961	Q9BY07
QGFVESMKIILGGSM	THBS3	181	P49746
GNLGGKIQMEMETVS	ZNF225	76	Q9UK10
LLYVSMKMGGTAGQS	TRAV1-1	6	A0A0B4J248
MKMGGTAGQSLEQPS	TRAV1-1	11	A0A0B4J248
GTEASGTGNMKFMLN	PYGL	671	P06737
GTGNMKFMLNGALTI	PYGL	676	P06737
KFMLNGALTIGTMDG	PYGL	681	P06737
GLENMGAAFQSMMTG	PTGR2	321	Q8N8N7
GAAFQSMMTGGNIGK	PTGR2	326	Q8N8N7
SMMTGGNIGKQIVCI	PTGR2	331	Q8N8N7
GAGAVQFMMTNKLDT	TMEM33	11	P57088
LLYVSMKMGGTTGQN	TRAV1-2	6	A0A0B4J238
GMNTIDQGMAALKLG	YTHDF2	181	Q9Y5A9
QQMMSSVGRAGAAAG	ZBTB7A	321	O95365
NAGLGLAIGMVDSSM	SLC18A1	396	P54219
RTVVMQGAAGIGKSM	NLRP12	211	P59046
KEMSQTLQGGNMLEG	MXRA5	1061	Q9NR99